APA

Aarts A. M. W. M., Duffy S. W., Geurts S. M. E., Vulkan D. P., Houssami N., Zappa M., Nagtegaal I. D., Verbeek A. L. M. & Broeders M. J. M. (20191203). Towards evidence-based follow-up intervals for breast cancer survivors: Estimates of the preclinical detectable phase of contralateral second breast cancer. : Breast (Edinburgh, Scotland).

Chicago

Aarts A M W M, Duffy S W, Geurts S M E, Vulkan D P, Houssami N, Zappa M, Nagtegaal I D, Verbeek A L M and Broeders M J M. 20191203. Towards evidence-based follow-up intervals for breast cancer survivors: Estimates of the preclinical detectable phase of contralateral second breast cancer. : Breast (Edinburgh, Scotland).

Harvard

Aarts A. M. W. M., Duffy S. W., Geurts S. M. E., Vulkan D. P., Houssami N., Zappa M., Nagtegaal I. D., Verbeek A. L. M. and Broeders M. J. M. (20191203). Towards evidence-based follow-up intervals for breast cancer survivors: Estimates of the preclinical detectable phase of contralateral second breast cancer. : Breast (Edinburgh, Scotland).

MLA

Aarts A M W M, Duffy S W, Geurts S M E, Vulkan D P, Houssami N, Zappa M, Nagtegaal I D, Verbeek A L M and Broeders M J M. Towards evidence-based follow-up intervals for breast cancer survivors: Estimates of the preclinical detectable phase of contralateral second breast cancer. : Breast (Edinburgh, Scotland). 20191203.